<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials
Image Overlay - Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

May 25, 2020

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Astrazeneca’s vaccine candidate has advanced to clinical trials with the prospect that it will be available by September. Yourway supports clinical trials to get them advanced to the clinic.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat
Come chat with us!
Hello! How can I help you?